Rallis India Peer Comparison

NSE: RALLIS | BSE: 500355

₹209.63

₹-0.61 (-0.29%)

As on 28-Aug-2026IST

Market cap

₹4,081 Cr

Revenue (TTM)

₹2,962 Cr

P/E Ratio

19.1

P/B Ratio

1.9

Div. Yield

1.4 %

Edit

	Rallis India	Sumitomo Chemical	Bayer Cropscience	Sharda Cropchem	Dhanuka Agritech
Market cap (₹ Cr)	4,081	25,848	18,202	7,072	4,350
Revenue (₹ Cr)	2,962	3,245	5,595	5,357	1,953
Net Profit (₹ Cr)	214.00	579.39	732.10	626.21	268.04
Net Margin (%)	7.12	17.04	12.71	11.46	13.42
RoE (%)	13.45	17.35	24.05	21.55	16.62
Price to Earnings	19.07	44.61	24.86	11.30	16.23
Price-To-Book	1.88	7.17	5.54	2.19	2.64

Income Statement (₹ Cr)

	Rallis India	Sumitomo Chemical	Bayer Cropscience	Sharda Cropchem	Dhanuka Agritech
Operating Revenue	2,896.65	3,238.32	5,675.00	5,267.59	2,019.79
Total Income	2,940.10	3,424.76	5,773.60	5,409.82	2,062.80
Total Expenditure	2,535.02	2,606.56	4,804.90	4,208.65	1,616.31
EBITDA	361.63	631.76	870.10	1,058.94	403.48
Depreciation	117.13	66.12	94.00	324.51	64.22
EBIT	244.50	565.64	776.10	734.43	339.26
Interest	11.42	8.44	19.80	21.16	3.71
Other Income	43.45	186.44	98.60	142.24	43.01
Exceptional Items	-26.23	-16.08	--	--	--
Profit before Tax	250.30	727.56	854.90	855.51	378.56
Provision for Tax	66.42	184.59	165.70	174.51	91.33
Profit after Tax	183.88	542.98	689.20	680.99	287.23

	Rallis India	Sumitomo Chemical	Bayer Cropscience	Sharda Cropchem	Dhanuka Agritech
Shareholder's Funds	2,042.97	3,389.67	2,965.70	3,136.49	1,681.88
Minority Interest	--	4.11	--	0.55	--
Non-Current Liabilities	619.84	110.17	3,107.80	235.57	49.56
Current Liabilities	1,580.13	969.81	2,947.10	2,517.61	370.59
Total Liabilities	4,248.66	4,473.76	9,033.00	5,890.22	2,102.02

	Rallis India	Sumitomo Chemical	Bayer Cropscience	Sharda Cropchem	Dhanuka Agritech
Non-Current Assets	1,577.96	1,133.61	3,722.70	1,320.70	584.68
Current Assets	2,663.69	3,340.15	5,297.90	4,569.51	1,517.34
Total Assets	4,248.66	4,473.76	9,033.00	5,890.22	2,102.02
Total Debt*	6.90	1.50	0.00	0.00	0.90
Net Current Assets	1,083.56	2,370.34	2,350.80	2,051.90	1,146.75
Contingent Liabilities	274.02	60.07	765.30	17.55	187.63

	Rallis India	Sumitomo Chemical	Bayer Cropscience	Sharda Cropchem	Dhanuka Agritech
Cash From Operating Activities	172.11	445.51	1,078.50	655.69	196.20
Cash Flow from Investing Activities	-94.88	-331.95	72.50	-513.07	-118.05
Cash from Financing Activities	-66.16	-82.88	-623.80	-118.28	-59.79
Net Cash Inflow / Outflow	11.07	30.68	527.20	24.34	18.36

	Rallis India	Sumitomo Chemical	Bayer Cropscience	Sharda Cropchem	Dhanuka Agritech
ROCE (%)	13.23	23.39	30.08	31.10	24.44
ROE (%)	9.32	17.26	23.70	24.16	18.62
ROA (%)	4.53	12.87	7.91	12.54	14.72
EBIT Margin (%)	13.98	25.27	17.07	22.80	22.11
Net Margin (%)	6.25	15.85	11.94	12.59	13.92
Cash Profit Margin (%)	8.25	16.95	11.69	18.03	16.17

	Rallis India	Sumitomo Chemical	Bayer Cropscience	Sharda Cropchem	Dhanuka Agritech
Revenue Growth (%)	8.78	2.85	3.68	21.94	-0.75
EBIT Growth (%)	26.67	8.68	19.70	78.08	-1.37
Net Profit Growth (%)	46.95	7.21	21.34	123.70	-3.28
EPS Growth (%)	46.95	7.41	21.34	123.69	-3.28
Book Value Growth (%)	7.28	16.84	4.05	25.43	19.90

	Rallis India	Sumitomo Chemical	Bayer Cropscience	Sharda Cropchem	Dhanuka Agritech
Price / Earnings	23.03	33.53	30.30	11.52	14.10
Price / Book Value	2.07	5.37	7.04	2.50	2.41
Dividend Yield (%)	1.38	0.36	3.22	1.72	0.22
EV/EBITDA	10.36	22.10	20.09	6.35	9.03
Market Cap (₹ Cr)	4,235.19	18,203.86	20,885.70	7,846.59	4,048.67

	Rallis India	Sumitomo Chemical	Bayer Cropscience	Sharda Cropchem	Dhanuka Agritech
Debt to Equity	0.00	0.00	0.00	0.00	0.00
Short term debt to equity ratio	0.00	--	--	--	0.00
Current Ratio	1.69	3.44	1.80	1.82	4.09
Quick Ratio	1.08	2.65	1.07	1.37	2.70
Interest Coverage	22.92	87.21	44.18	41.43	103.07

	Rallis India	Sumitomo Chemical	Bayer Cropscience	Sharda Cropchem	Dhanuka Agritech
Debtors to sales (%)	21.25	22.72	19.66	45.36	21.82
Asset Turnover	0.90	0.85	0.77	1.03	1.11
Receivable days	57.86	77.14	56.33	142.20	75.54
Inventory Days	85.52	74.64	122.54	68.45	76.86
Payable days	126.20	95.86	131.57	151.79	55.32
Cash Conversion Cycle	17.18	55.92	47.30	58.86	97.08

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.